The examination of concentration of drug in tissues from the knee osteoarthritis patients who use the Esflurbiprofen tape or Flurbiprofe
Not Applicable
- Conditions
- osteoarthritis
- Registration Number
- JPRN-UMIN000024789
- Lead Sponsor
- Tokyo Medical and Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 14
Inclusion Criteria
Not provided
Exclusion Criteria
the patients who have history of trauma or a complication the patients who treated with NSAIDs, hyaluronic acid, steroid.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We evaluate the concentration measurement of Esfl urbiprofen and Flurbiprofen, the blood concentration of PGE2, the change of NRS at 7 days after starting the medication.
- Secondary Outcome Measures
Name Time Method